BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38627724)

  • 21. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
    Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of dental floss traction-assisted endoscopic submucosa dissection to rectal neuroendocrine neoplasm].
    Shi Q; Sun D; Zhong YS; Xu MD; Li B; Cai SL; Qi ZP; Ren Z; Zhang H; Yong YY; Yao LQ; Zhou PH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):377-382. PubMed ID: 31054553
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10-20 mm rectal neuroendocrine tumors: a multicenter, retrospective study of 10-year experience.
    Goo JJ; Baek DH; Kim HW; Lee HS; Lee JY; Park SB; Song GA; Lee SH; Lee JH;
    Surg Endosc; 2023 Jul; 37(7):5196-5204. PubMed ID: 36947224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: an Analysis of the National Cancer Database.
    Zhao B; Hollandsworth HM; Lopez NE; Parry LA; Abbadessa B; Cosman BC; Ramamoorthy SL; Eisenstein S
    J Gastrointest Surg; 2021 Feb; 25(2):484-491. PubMed ID: 32016672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
    Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
    Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
    Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
    Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A
    World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):405-413. PubMed ID: 28986041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
    J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers].
    Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].
    Huang YT; Jia R; Xu Q; Ji SJ; Cui HT; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):146-151. PubMed ID: 30862146
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
    Wang Z; Liu Z; Wen Z; Li R; An K; Mei S; Chen J; Shen H; Li J; Zhao F; Wei F; Xiao T; Liu Q
    Eur J Surg Oncol; 2021 Dec; 47(12):3166-3174. PubMed ID: 34294465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
    Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
    Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New lymph node staging for rectal neuroendocrine tumors.
    Fields AC; McCarty JC; Ma-Pak L; Lu P; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
    J Surg Oncol; 2019 Jan; 119(1):156-162. PubMed ID: 30481376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
    Wang Y; Zhang Y; Lin H; Xu M; Zhou X; Zhuang J; Yang Y; Chen B; Liu X; Guan G
    J Surg Oncol; 2021 Dec; 124(7):1098-1105. PubMed ID: 34291822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Russell MC; Cardona K; Sullivan PS; Maithel SK
    J Surg Oncol; 2019 Nov; 120(6):932-939. PubMed ID: 31448820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.